Schedule 13G ownership disclosure
OKYO PHARMA LTD
Common · CUSIP: G6724L116
Event date: 2025-12-31
- Filing-level shares
- 3,802,194.00
- Percent of class
- 9.5%
- Chernett Jorey
Shares: 3,802,194.00 · Class: 9.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002042077-26-000017
- Form type
- SCHEDULE 13G/A
- Filer
- Chernett Jorey
- CIK
- CIK 2042077
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership